Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Irvine › NPI 1306418934
Lab

Reopen Diagnostics LLC

Reopen Diagnostics LLC was paid $0.00 by Medicaid between May 2022 and Aug 2022, across 2 billing codes. Its largest line is U0005, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 — 0% of everything it billed.

33Billing provider infoREOPEN DIAGNOSTICS LLC
IRVINE, CA 92617
33aNPI1306418934assigned 07/13/2021
28Total paid$0.00
24GClaims222
24DCodes billed2
24AFirst – last monthMay 2022 – Aug 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#551 of 561
Median peer was paid$222K
This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022222$0.00
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 111 47 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 0% 111 47 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBADAL, JONATHAN (CEO)
Parent organizationOPENTRONS LABWORKS INC.
Same official

Other billing entities under BADAL, JONATHAN

Full network →
ProviderLocationPaid
Reopen Diagnostics LLCLong Island City, NY$9K
Reopen Diagnostics LLCLong Island City, NY$7K
Reopen Diagnostics LLCRockville, MD$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.